Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3490637019 | Product containing methyclothiazide and reserpine (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3715729015 | Methyclothiazide- and reserpine-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Methyclothiazide- and reserpine-containing product | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
| Methyclothiazide- and reserpine-containing product | Is a | Methyclothiazide-containing product | true | Inferred relationship | Some | ||
| Methyclothiazide- and reserpine-containing product | Is a | Reserpine-containing product | true | Inferred relationship | Some | ||
| Methyclothiazide- and reserpine-containing product | Has active ingredient | Centrally acting antihypertensive agent | false | Inferred relationship | Some | ||
| Methyclothiazide- and reserpine-containing product | Has active ingredient | Reserpine | true | Inferred relationship | Some | 2 | |
| Methyclothiazide- and reserpine-containing product | Has active ingredient | Methyclothiazide | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Methyclothiazide- and reserpine-containing product in oral dose form | Is a | True | Methyclothiazide- and reserpine-containing product | Inferred relationship | Some | |
| Methyclothiazide and reserpine only product | Is a | True | Methyclothiazide- and reserpine-containing product | Inferred relationship | Some | |
| Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet | Is a | False | Methyclothiazide- and reserpine-containing product | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR